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Abstract
The unprecedented health care effects, and consequences of COVID-19 have been felt
disproportionately within distinctive races and older adults, especially African Americans. An
individual’s race, comorbidities, age, and other determinants of health impact level of inclusion
in society also influencing an individual’s susceptibility to developing COVID-19. Over 42
million people in the United States have tested positive for the COVID-19. Reluctance in the
COVID-19 vaccination within the Black community can delay the closure of the race mortality
gap seen with COVID-19.
Increasing COVID-19 vaccination awareness in Blacks ages 55 and older population at a
South Florid a medical center using a voice-recorded culturally sensitive program was the
primary focus of the quality improvement program. The presentation illustrates the challenges
associated with COVID-19, vaccine information, and local vaccine sites. Upon completion,
participants completed a program questionnaire. The questionnaire administered using Qualtrics
consisted of 10 questions used to evaluate COVID-19 vaccination acceptance rates, COVID-19
severity risk, along with effectiveness and benefits of the QI program.
A total of 33 subjects participated in the study, results were combined for analysis and
significance of the wellness program. Results suggest 67 % (n=22) of participants were assigned
a COVID-19 severity risk for strong, 30% (n=10) medium risk and 3% (n=1). Approximately,
97% (n=32) of participants found the program to be beneficial, while 3% (n=1) reported no
benefit. Of the 33 participants included in the study 33% (n=11) of participants were
unvaccinated and 67% (n= 22) reported being vaccinated. Of the 11 participants that were
unvaccinated, 91% (n=10) participants were willing to get vaccinated post intervention and 7%
(n=1) of participants reported no interest in vaccination at all. Approximately 67% (n=22) of
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participants reported having little to no knowledge regarding the COVID-19 vaccine pre
intervention, this decreased to 6% (n=11) post intervention. Findings suggest 33% (n=11) of
participants reported having moderate to extreme knowledge regarding the vaccine pre
intervention this increased to 94% post intervention, suggesting a 61% increase in patient
awareness regarding COVID-19 vaccines. Conclusively, using a confidence interval of 95% and
a set p-value of 0.05, we were able to calculate a z-score to determine the QI program
implemented yielded statistically significant results.
In conclusion, the voice-based QI program is a cost-effective and efficient program for
improve vaccination rates in African Americans. The information provided improved COVID-19
vaccination acceptance in African Americans ages 55 and up while promoting health literacy and
primary preventative services. In the future, the framework of the program can be implemented
for other wellness programs and catered to other languages.
Keywords: COVID-19 vaccine, COVID-19, vaccine acceptance, health disparities, racial
disparities, coronavirus, vaccine hesitancy, African- American, elderly.
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Introduction
Over the last year, the coronavirus has rapidly evolved into a global health tragedy and

lead to economic destruction. The world-wide pandemic has shown to have rapid rate of
transmission and a high rate of mortality. The corona virus pandemic has deemed itself more
than just and healthcare crisis, disrupting several aspects of one’s life from employment, family
life, education, and economic stability. The coronavirus disease, according to the Center for
Disease Control (2020), data indications reflect a disproportionate rate of incidence and mortality
rates among ethnic minority communities (Malik et al., 2020). As vaccines are being deployed it
is the responsibility of healthcare providers to disseminate culturally appropriate and accurate
information to the community to increase vaccine awareness and acceptance in vulnerable
populations. There is an importance for healthcare providers, public health officials and
policymakers to prioritize vaccination acceptance in vulnerable populations such as African
Americans. The purpose of this quality improvement project is to 1) assess COVID-19
vaccination rates in Florida 2) identify vulnerable minority populations, 3) implement a
culturally sensitive and educational quality improvement (QI) intervention 4) administer an
electronic questionnaire via Qualtrics to assess QI program and effects on vaccination acceptance
rates 5) Evaluate QI program and calculate each individuals risk of severe complications if a
patient were to contract COVID-19 in relation to participants number of chronic illnesses.
Problem Statement
Ethnic minority groups such as the African American population have not been exempted
the disproportionate health disparities of COVID-19. Furthermore, the risk for severe illness
surges with age and associated medical conditions. Lack of COVID -19 awareness and
vaccination will only contribute to the disproportionate rise in morbidities and mortality.
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Throughout history, African American have displayed an increased prevalence and mortality rate
in relation to chronic diseases. Furthermore, underlying health care conditions increase the risk
of severe illness from COVID-19. The pandemic has unmasked vulnerabilities regarding health
disparities affecting people of color. Two main distributors have been approved for rapid
deployment of vaccine administration, Moderna and Pfizer. Lack of knowledge between the two
vaccines and the vaccine approval process has left many citizens questioning efficacy and
acceptance. While the disease continues to rapidly spread and the US currently leading globally
with over 42 million cases and over 672,000 deaths, health care professionals have a
responsibility to culturally educate minority populations. Hesitancy in vaccine acceptance and
administration impedes closing the race mortality gap seen in African Americans developing
COVID-19. Successively, building confidence with knowledge can assist in vaccination
administration.
II. Summary of Literature
A. Literature Search
The following literature search was conducted to investigate the impact of COVID-19
awareness on vaccination acceptance in the elderly African American community. The literature
search involved searching keywords related to the PICO question, “Can Implementing a cultural
focused COVID-19 vaccine awareness education program increase COVID-19 awareness and
immunization in African American communities ages 55 years or older?”. Once the clinical
question was generated, the investigation process was initiated, including sourcing relevant
evidence-based studies from databases regarding the practice question. Several research engines
were utilized to guide the research related to the COVID-19 vaccine acceptance and elderly
minorities.
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Research databases include EBSCO, CINAHL, and Google Scholar. Keywords used to facilitate
the search included COVID-19 vaccine, COVID-19, vaccine acceptance, health disparities, racial
disparities, coronavirus, vaccine hesitancy, African- American, elderly.
Due to the relevance of the topic all studies meet inclusion criteria, studies evaluated
were within five years. All studies evaluated for the quality improvement project were conducted
between 2020 and 2021. Inclusion criteria integrated literature reviews, systemic reviews, and
meta-analysis studies. Articles were also sorted based on the exclusion criteria, articles related to
non-human subjects, patients below 55 years old, and articles not written in the English
language. The literature search produced 126 articles on all databases combine, studies were
screened based on inclusion and exclusion criteria, 13 articles were identified to include in
literature summary.
Figure 1.

Literature Search Databases
EBSCO, CINAHL, Google
Scholar

Total Relevant Research
N= 124

C. Literature Review
1. Safety and Efficacy of COVID-19 Vaccines

Studies Included
N= 11
Studies Excluded
N= 113

Inclusion and Exclusion
Criteria Sorting
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When accepting a COVID-19 vaccine, individuals would prefer one that is safe and
effective. Unfortunately, no one drug has been identified as definitive treatment for the corona
virus. As a result, to come close to eradicating the pandemic, mass vaccination is critical.
However, concerns have been raised regarding the quickness in creating, manufacturing, and
distributing the vaccine. Throughout life many are taught quick fixes do not lead to long term
solutions. As a result, a quick vaccine raises concerns regarding vaccine efficacy in Americans.
The article “Safety and Immunogenicity of Two RNA-based Covid-19 Vaccine Candidates”,
aims to explain safety and immune response from phase 1 of trails of the BNT162b1(vaccine A)
and BNT162b2 (vaccine B) vaccine. Both vaccines consist of a modRNA platform and process.
However, differ in their nucleotide sequence that encode vaccine antigens (Walsh et al., 2020).
The trial was double-blinded, placebo controlled, observer-blinded, and dose escalated. A total of
195 participants were placed in 13 different dosing groups consisting of 15 participants each.
Within each group 12 would receive the same dose of their assigned vaccine and 3 participants
would receive the placebo at random. Vaccine dose levels ranged between 10-30 micrograms
and a group of 100 micrograms (Walsh et al., 2020). Results reported lower incidence rates and
lower severe reaction rates with vaccine B in older adults. As a result, vaccine B at the 30
micrograms dose was elect for continuation to phase 2 and phase 3 trials to assess efficacy.
Immunogenicity of both vaccines increased with age.
The race for manufacturing and successfully approving a COVID-19 vaccine has been on
the forefront of many companies. Technology has been exploited to develop the first vaccines to
address the rising mortality and prevalence rates of the coronavirus. Safety and efficacy are a
priority for Americans when accepting vaccines. The article “Safety and Efficacy of the
BNT162b2 mRNA Covid-19 Vaccine”, researchers address the remaining trial phases for the
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more effective vaccine, 30 micrograms of BNT162b2, 21 days apart. Vaccines were
administered to patients 16 years old and older. BNT162b2 is a lipid nanoparticle formulated,
nucleoside-modified RNA vaccine that encodes the Sars-CoV2 full length protein spike (Polack
et al., 2020). A total of 43.548 participants were included in the study, participants were split into
two groups. On group was administered the Pfizer funded vaccine while the other group was
injected with placebo. Results suggest 8 cases of COVID-19 were identified in the experimental
group and 162 participants were diagnosed with COVID-19 from the placebo group after the
second dose was administered. As a result, researchers suggest BNT162b2 is 95% effective
towards preventing COVID-19 (Polack et al., 2020). Adverse effects of both groups were
minimal, safety of vaccine administration was determined by mild to moderate pain at the
injection site.
The review “Prospects for a safe COVID-19 vaccine” address the rigorous and studies
and phases required to develop an efficacious vaccine. To build vaccine confidence in Americans
it is imperative that patients feel they are receiving a safe and effective vaccine. The Accelerating
COVID-19 Therapeutic Interventions and Vaccine (ACTIV) Working Group aim to evaluate the
immunity benefits from COVID-19 vaccines and corona virus infections. ACTIV address the
lack of evidence surrounding vaccine associated enhanced diseases (VAED), researchers
suggest, to achieve herd immunity the COVID-19 transmission rates must be controlled. In the
last 10 years, vaccines have saved at the minimum 23 million lives (Haynes et al., 2020). The
vaccine development process can be timely and rigorous, prior to administering a vaccine,
several characteristics of the vaccine must undergo research and experimentation to asses’ risks
and benefits. Ultimately, researchers aim to review pertinent research and assess the likelihood
of enhanced diseases from the COVID-19 vaccine (Haynes et al., 2020).
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2. Determinants of Vaccine Acceptance
Globally, the COVID-19 virus has resulted in health and economical burdens to patients
and families. Herd immunity by COVID-19 vaccine immunization has the potential to bring the
virus to a pivotal end. According to Mayo Clinic (2020), herd immunity is attainable if at least
70% of the population is vaccinated. Herd immunity can decrease transmission rate and allows
for protection to those not vaccinated. The study “The Factors Associated with US Adults’
Likelihood of Accepting COVID-19 Vaccination” aimed to assess factors associated with
research participant’s likelihood of accepting and receiving the COVID-19 vaccine. Researchers
hypothesize a widespread acceptance of the COVID-19 vaccine is fundamental to stem the virus.
The study consisted of 1971 participants, 14% blacks, surveyors were assessed on their readiness
to receive a proposed COVID-19 vaccine (Kreps et al., 2020). In addition, participants were
provided full details two hypothetical vaccines and given the option for two different vaccines or
neither.
A correlation was seen with increase in vaccine efficacy and vaccine acceptance.
Marginal mean willingness increased with various factors of vaccination ability to prevent
transmission. An efficacy of at least 70-90% for a COVID-19 vaccine was correlated with a
higher probability of acceptance. Acceptance also increased with endorsements from the Center
for Disease Control and Prevention and the World Health Organization. Ultimately, results
suggest vaccine elements and political support influenced vaccine selection and acceptance.
The article “The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine
Formulation”, addresses the need for a safe and effective vaccine to control the continuous
detrimental effects of the pandemic. Several factors play a role in the disproportionate morality
rates of the disease. The COVID-19 virus has significantly impacted two populations in

COVID-19 VACCINE AWARENESS IN BLACKS AGES 55 AND UP

12

particular, elderly and minority populations. The increase in mortality rates of vulnerable
populations places an emphasis on an urgent need for development, manufacture, and
distribution. Furthermore, researchers explain the current vaccines in clinical trials, along with
their benefits and restrictions. The review also tackles the challenges associated with
administration and dissemination. Researchers suggests different needle free modes of
administration may assist with increasing vaccination rates in a short time (Wang et al., 2020).
Vaccine have been placed as the upmost priority in the health and policy sectors. To
obtain herd immunity, vaccines must be accepted by majority of the population as previously
stated. To prevent drastically rising death rates, vaccines must be widely accepted. The article
“Determinants of COVID-19 vaccine acceptance in the US” aims to identify the current vaccine
acceptance, vulnerable populations, and ways to disseminate information to target populations.
The research consisted of 672 participants reflecting the US population, participants completed a
questionnaire to assess likelihood of vaccination and if a correlation exists if influenza vaccinate
uptake. About 67% of participants report they would receive a vaccine if made available. Older
adults about 78% (age >55 years old) would receive the COVID vaccine once available.
Throughout the study researchers were able to identify demographic and geographical disparities
in vaccine acceptance rates (Malik et al., 2020). In conclusion, researchers suggest policymakers
and public health officials need to prioritize vaccine acceptance in vulnerable populations.
3. Aging and Racial Disparities Correlated with COVID-19
A study conducted by John Hopkins University aimed at addressing the prevalence of
COVID-19 vaccine reluctance and influences affecting vaccine intentions. The study was able to
utilize the National Opinion Research Center (NORC) US national survey data to examine the
relationship between vaccine intention and prevention behaviors (Latkin et al., 2021).
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Furthermore, researchers were able to correlate racial differences in participants and vaccine
intention. A total of 1,056 participants were invited to complete the survey, a total of 1,043
participants completed the survey in either English or Spanish. The dependable variable was
measured by assessing participant willingness to accept a COVID-19 vaccine once available.
The survey addressed vaccine intention, COVID-19 social behaviors, covariates, and reasons for
lack of vaccination. Results suggest approximately 17% of participants report no intention of
receiving the vaccine and about 30% of participants were unsure of receiving the vaccine.
According to the study, Black and Latino participants reported less likely to receive the vaccine.
Researchers conducted a sub-analysis using Fisher’s exact Tests to assess reasons for lack
of vaccination, results suggest a significant difference racial/ethnic difference in participants
reporting no intention or uncertainty with receiving the COVID-19 vaccine. One major concern
contributing to the lack of vaccination included concerns for viral transmission from the
vaccination. About 66% of Blacks and 47% of Hispanic participants (Latkin et al., 2021).
Ultimately, researchers suggest public health awareness programs are vital for increasing vaccine
uptake and in greater detail for concerns in the Black and Latino community.
The study conducted by Texas Agricultural and Mechanical University reveals
correlations of COVID-19 vaccination hesitancy and common reasons for vaccine refusal. Over
the last year the United States continues to battle the coronavirus pandemic that has rapidly
progressed resulting in a global health crisis. According to the Center for Disease Control (2020),
Black and Hispanics diagnosed with COVID-19 are more than four times more likely to be
hospitalized during the course of the virus when compared to Whites. The COVID-19 pandemic
was accompanied with massive conflict regarding health, travel, trade, and global economy. The
study involved surveying over 5,000 Americans nationally, regarding their behaviors and
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thoughts towards COVID-19. The study indicated approximately 40% response rate and 65%
completion rate (Callaghan et al., 2020). Overall, 31% of surveyors have no intention of
receiving the COVID-19 vaccination. A lack of vaccination acceptance can hinder the goal of
herd immunity to hinder the spread of the COVId-19 virus. Ultimately, researchers reveal the
issues surrounding vaccine hesitancy in effort to improve health communication to increase
COVID-19 vaccination rates.
The study “Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks”
aims to address the reasons for low vaccination acceptance rates in the Black community. Blacks
have been disproportionately affected by the coronavirus compared to other races (Momplaisir et
al., 2020). As history has shown, the Black community has a higher prevalence and mortality
rate for chronic diseases. Reluctance in the COVID-19 vaccination in the Black community can
impede the closure of the race mortality gap seen with COVID-19. Researchers aimed to canvas
COVID-19 hot spots in the Black community to organize focus groups addressing attitudes of
the black community (Momplaisir et al., 2020). Guided by the ground theory, a total of 24
participants were included in the study and separated into 4 focus groups, 89% were black.
Researchers were able to identify a high rate of vaccine hesitancy in the community. Ultimately,
researchers suggest healthcare provider intervention with vaccine recommendations and
transparency is the best way to address hesitancy in the Black community.
The review “Disproportionate impact of the COVID-19 pandemic on immigrant
communities in the United States” attempts to address the potential impact of the corona virus on
immigrants. The study based out in Texas, suggests hot spot states are experiencing high
mortality rates in minority groups. Researchers propose high mortality rates in minority groups is
directly correlated with increase in comorbidities, socioeconomic status, and lack of healthcare
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access. Texas has 1.6 million immigrants in Houston, patients report reduced internet, phone
access and limited ability to speak English are factors that can increase likelihood of contracting
COVID-19. Researchers propose policy recommendations, increased healthcare access and
culturally catered care can assist with addressing disproportionate impacts of COVID-19 on
minority groups (Clark et al., 2020).
Lastly, the study “COVID-19 Vaccination Hesitancy in the United States: A Rapid
National Assessment”, bring forth the concerns of Americans in relation to immunization on a
national level. Researchers developed a questionnaire administered to 1,878 participants,
consisting of 26% Non-white or Hispanic participants and 19% of participants were Hispanic.
The likelihood of accepting a vaccine was very likely at about 52% and the remaining 48%
expected hesitancy or rejection of the vaccine. Results suggest vaccine hesitancy was increased
in African American participants (34%) and Hispanics (29%). Given the rapid spread of disease,
a priority needs to be placed on mass vaccination and distribution of information. Researchers
propose special attention is warranted to minority groups and an emphasis needs to be placed on
evidence-based communication, media distribution and policy measures (Khubchandani et al.,
2020).
III.

PICO Question and Objectives

Can Implementing a culturally focused COVID-19 vaccine awareness education program
increase COVID-19 awareness and immunization in African Americans ages 55 years or older?
A. Primary DNP Project Goal and Objectives
The impact of the COVID-19 pandemic and associated health consequences has been felt
differently across different ethnic and age groups. In March 2020, once the COVID-19 evolved
into the United States (US), social status was quickly divided by essential and non-essential
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employment. While a portion of the nation was transitioning to working and schooling from
home, the other portion was forced to expose themselves to the COVID-19 virus to maintain the
functionality of society. Ultimately, the impact of COVID-19 on health was significantly
influenced by social determinants and health disparities.
As previously stated, unambiguously, COVID-19 has disproportionately impacted mortality
rates in African Americans in comparison to the White population. Throughout history, the
African American community has been at greater risk of developing diabetes, high blood
pressure and cardiovascular disease, all high-risk factors for COVID-19 (Greenway et al., 2020).
According to Greenway and colleagues (2020), as of June 2020, African Americans and Latino’s
comprise 21.8% and 33.8% of the US COVID-19 cases, and individually account for 13% and
18% of the American population. The extent of one’s health is significantly influenced by
several social determinants.
Lack of knowledge is a social determinant of health that can impact the health and well-being
of an individual. The extent of one’s health is significantly influenced by several factors, one
being their quality of education. As a result, educational inequality can be considered as an
underlying cause for many health disparities in the Black community. A lower level of education
or English proficiency can place the Black community at a health disadvantage and increase their
incidence of illness such as COVID-19. Furthermore, A lack of patient knowledge and
understanding can often lead to mistrust in the health care system. Many African Americans
have a lingering mistrust in the healthcare system after the notorious Tuskegee study that
deluded African Americans into thinking they were receiving free healthcare when the study was
essentially designed to trace the course of untreated syphilis. Lack of knowledge and other health
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disparities in addition to a rapid vaccine distribution can further the level of mistrust in
immunization.
Second, lack of credible information reaching heavily impacted communities increases the
risk of disease and transmission. Educational interventions customized to linguistic, cultural, and
social circumstances of the African American population is crucial to preventing transmission of
preventable illness and increasing awareness and acceptance of primary prevention vaccines. In
addition, health care providers play a major role in bridging the gap in healthcare knowledge and
healthcare outcomes. Several factors influence the reluctance in African Americans when
deciding to be immunized, hesitation on safety and efficacy, uncertainty with rapid deployment
of vaccines and, mistrust regarding the motivation and mandates of the vaccine. Hence,
healthcare providers play a vital role in empowering patients to take control of their own health
and eliminating healthcare inconsistencies. Healthcare providers need to address doubtfulness
with accurate and culturally appropriate information to build confidence in patients. Standardized
treatment and COVID-19 management protocols should be in place for all patients despite
English proficiency. The COVID-19 vaccination awareness quality improvement program places
health equity as the main principle.
Vaccines are the most efficient interventions for addressing and terminating the COVID-19
pandemic. The COVID-19 vaccination can reduce mortality and morbidity rates in relation to
viruses and diseases. According to Mayo Clinic (2020), herd immunity is attainable if at least
70% of the population is vaccinated. The vaccine can offer improved healthcare outcomes in two
ways, direct and indirect protection. Directly, by preventing disease in the those vaccinated and
indirectly in those unvaccinated by reducing transmission in vaccinated individuals.
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The primary goal of the COVID-19 Awareness Program was to successfully implement a
quality improvement program at Medical Center in South Florida to increase COVID-19
vaccination awareness in the Black ages 55 years or older population. The program aimed to
decrease hospitalizations and deaths related to COVID-19 in African Americans while
disproportionately increasing vaccination awareness and rates. The South Florida medical center
has been providing primary care to a large population of Black patients in Fort Lauderdale since
1996, with 95% of patients being of African American ethnicity. The practice currently provides
primary care to over 2,000 patients, averaging about 10 – 30 patients a day depending on
availability of additional providers. Ultimately, the awareness program aimed to provide
culturally sensitive and accurate health information regarding the COVID 19 virus and vaccines
in effort to improve vaccination awareness and immunization in the target population. With
successful implementation the COVID-19 Vaccination Awareness Program, in the future health
care providers can partner with patients and communities to decrease negative healthcare effects
caused by COVID-19 disparities while advocating for structural change (Tai et al., 2020).
B. Quality Improvement Objectives
1. Identify a primary care office with a large ethnic patient population in an underserved
populated area. Ethnic groups to include African American patients ages 55 years or
older for a duration of 14 days
2. Create COVID-19 awareness program for African American minorities within 2 months
3. Analyze current target patient census with office manager to identify potential patient
outreach within 2 months
4. Establish a protocol for implementing the COVID-19 Awareness Program and begin
educational interventions within 8 months
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5. Evaluate COVID-19 vaccination awareness acceptance and vaccine immunization among
elderly African American minorities after 2-week program implementation.
IV. Definition of Terms
Corona Virus Disease (COVID-19): an infectious disease caused by the corona virus resulting
in severe respiratory illness in most people infected (WHO, 2020).
Black or African American: a person having origins in any of the black racial groups of Africa
(CDC, 2015)
Race: grouping of people based on shared physical characteristics (CDC, 2015).
Ethnicity: ethnic quality or affiliation with a group based on shared attributes (MerriamWebster, 2021).
Elderly: being past middle age, relating to a point later in life (Merriam-Webster, 2021).
Vaccines: a manufactured product that offers protection by stimulating one’s immune system to
develop immunity when a specific disease is introduced to the body (CDC, 2018).
Immunity: protection from an infectious disease (CDC, 2018).
Herd Immunity: When a sufficient portion of a population is vaccinated or immune to an
infectious disease in effort to diminish rate of transmission (CDC, 2020).
Pfizer Vaccine: an intramuscular FDA emergency use approved mRNA vaccine to prevent
COVID-19 in patients 16 years of age or older
Moderna Vaccine: an intramuscular FDA emergency use approved mRNA vaccine to prevent
COVID-19 in patients 18 years of age or older
Patient Satisfaction: an indicator for measuring the level of happiness with one’s healthcare
Health Literacy: the ability of an individual to use, find and understand health information to
make informed health decisions for themselves or others (CDC, 2021).
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Social Determinants of Health: conditions in environments of daily living that influence health,
healthcare outcomes and risks (CDC, 2021).
Native Language: language spoken in one’s country of origin or one’s primary language
(Merriam-Webster, 2021).
Culturally Sensitive: being culturally aware, have knowledge and accepting of other cultures
and identities (Merriam-Webster, 2021).
Health Disparities: preventable variances in burden of disease, injury, violence, or opportunities
to achieve optimal health inhibited by social disadvantages (CDC, 2017).
Visual-based education: learning style where the learner needs to see the information for
processing
Pamphlet: A printed booklet of information (Merriam-Webster, 2021).
Questionnaire or Survey: a set of questions for obtaining statistical or personal information
(Merriam-Webster, 2021).
V. Conceptual Underpinning and Theoretical Framework
The theory of planned behavior is a framework aimed at explaining and predicting behaviors
(Steinmetz et al., 2016). The theory suggests the driving force behind behaviors is the intent to
implement the behavior. Consequently, intent is influenced by motivational variables (Steinmetz
et al., 2016). Utilizing the theory of planned behavior can assist with designing health behavioral
changes, vaccine acceptance and literacy. The purpose of the study was to improve COVID-19
vaccination acceptance and immunization in African Americans ages 55 and up while promoting
health literacy and primary preventative services.
VI. Methodology
A. PDSA Quality Improvement Method
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As previously stated, The COVID-19 pandemic is a growing healthcare burden associated
with several comorbidities and becoming one of the leading causes of hospitalizations across the
nation. Furthermore, African Americans and elderly patients are at increased risk of developing
healthcare complications because of the COVID-19 virus. When a patient is elderly, African
American and diagnosed with a chronic illness, their chance of mortality increases significantly
if they contract the COVID-19 virus and the impact on quality of life can be profound. s
The COVID-19 Awareness Program aimed to educate patients on the COVID-19 virus,
significance of COVID-19 immunizations, preventative measures for improving positive health
behaviors, and vaccine acceptance. Ultimately, increased costs in healthcare are influenced by
unhealthy behaviors which lead to increased health risks, health deterioration and promote an
unhealthy lifestyle leading to increased mortality and morbidities. Subsequently, effective
communication, willingness to prevent COVID-19, culturally competent education and a reliable
support system can significantly impact the effectiveness of the program.
The plan, do, study and act (PDSA) model is a four-step continuous clinical model
focusing on quality improvement in the healthcare setting. The systemic processes can be echoed
several times in different ways until a prime solution is achieved. Each component of the clinical
model is critical to the success of the implementing the quality improvement intervention. Using
the continuous cycle, we can identify the clinical problem, decreased vaccination rates in African
American elderly patients. Next, an approach was formulated to resolve the issue of decreased
vaccination rates, by generating goals and objectives for the foundation of the QI program. Once
implemented, the program facilitated the next portion of the cycle allowing for collecting and
analyzing for comparison against goals and objectives. Lastly, with successful implementation of
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the program, strategies can be permanently implemented to maintain improved outcomes
addressing the clinical problem.
During the Act phase failures and success of the program were measured, evaluated, and
corrected to ensure expected solutions and minimize challenges and barriers towards the clinical
solution. The COVID-19 Awareness Vaccination Program prioritized improving quality of life in
African American patients ages 55 years or older in conjunction with increasing herd immunity
to optimistically bring the COVID-19 pandemic to a pivotal end. Secondly, the program aimed to
reduce health disparities and inconsistencies related to lack of knowledge, improve primary
prevention compliance, improve patient retention, and improve patient moral.
To be successful, a quality improvement program must be well organized, a collaborative
effort and use analytics to track positive changes and yield optimal results. The COVID-19
Awareness Program aimed to prioritize immunization and improved healthcare relationships to
avoid the negative effects of the COVID-19 virus. The quality improvement team consisted of
the DNP program leader, front desk secretary, DNP prepared faculty and a medical physician.
Ultimately, frontline healthcare providers have the most interaction with patients and can
significantly influence health behavioral changes.
B. Planning Phase
1. Study Design
The quality improvement program followed a team guided approach for roles and
responsibilities. Data collection included age, ethnicity, patient knowledge of COVID-19
vaccines pre and post intervention, and patient satisfaction with the COVID-19 awareness
program. A recruitment ad was displayed at the front desk to promote program participation.
Recruitment was conducted by front desk secretary, identifying African American patients ages
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55 and up. An informational letter was provided in either English or Creole regarding voluntary
participation at the beginning of the presentation. Recruitment consisted of identifying
participants eligible for the quality improvement program. Once processed by the medical
assistants for labs and vitals patients were placed in their individual exam rooms. Once in the
exam room front desk personnel provided the educational intervention, a voice-recorded
PowerPoint presentation catered to the patient’s preferred language of either English or Haitian
Creole.
Upon completion of the voice recorded presentation, the last slide provided participants
with direct link or QR code for personnel device use to an online questionnaire. The online
questionnaire was administered via Qualtrics for evaluation of COVID-19 vaccination
acceptance rates, along with effectiveness and benefits of the quality improvement program.
Following, patients were seen by primary the care provide for their routine office visit and to
address any additional concerns regarding COVID-19. All clinical issues or questions were
directed to participants treating physician. Upon check out, patients were provided with a
pamphlet regarding COVID-19 facts, COVID-19 vaccination information and local vaccination
sites in either English of Haitian Creole.
The DNP project leader was advised by Doctoral faculty and a board-certified internal
medicine medical doctor. The project leader met quarterly with clinical preceptor to analyze and
discuss data collected throughout the duration of the quality improvement program. The COVID19 vaccination awareness program was administered in the most common primary languages in
the South Florida’s African American population, English and Haitian Creole. The native
language catered program aimed to promote health literacy, address health inequalities, improve
patient satisfaction with healthcare provider, and COVID-19 precaution compliance. The Creole

COVID-19 VACCINE AWARENESS IN BLACKS AGES 55 AND UP

24

and English voice recorded presentations were uploaded onto two iPad tablets. Upon discharge
patients were provided a primary language catered pamphlet with basic information regarding
the COVID-19 vaccine and local immunization sites.
The total cost for implementing the COVID-19 vaccination awareness program was
estimated at $397.11. Translational services for informational letter, survey and printed
informative pamphlets regarding COVID-19 vaccines, sites locations, vaccination requirements,
and common questions in English, and Creole were $ 214.46. Sanitation supplies to sanitize
tablets after each use cost $18.65. Qualtrics was utilized for patient questionnaires in Haitian
Creole and English and for result analysis. Medical provider participated in the study conducting
routine patient visits to address any additional COVID-19 concerns expressed by patients or
regarding individual COVID-19 vaccination restrictions for patients. As a result, additional costs
for office personnel are not incurred, and program was implemented during office hours.
2. Sampling
All participants were 55 years of age or older and of African American descent.
Participants younger than the age of 55 years and of other ethnicities were excluded from
the quality improvement program.
3. Setting
The prospective quality improvement program was implemented for patients in a
single primary care setting at South Florida Medical Center for a period of 14 days. The
practice currently provides primary care to over 2,000 patients, averaging about 10 – 30
patients a day depending on availability of additional providers. Approximately, 95% of
patients seen at the South Florida medical are of African American ethnicity.
4. SWOT Analysis
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A SWOT analysis tool is beneficial for evaluating the strengths and weaknesses in a
quality improvement program. The tool aims to explore the strengths, weaknesses,
opportunities, and threats of an intervention (Moran, Burson & Conrad et al., 2016). The
analysis was implemented to assess the COVID-19 Awareness Program. Intrinsic factors
are identified as strengths and weakness that can impact the program negatively or
positively (Table 1). Next, extrinsic factors that could help or hurt the program were also
identified (Table 1).
Table 1: SWOT analysis
Internal Factors
•
•
•
•
•
•
•
•
•
•

Strengths
Doctoral prepared preceptor
Staff involvement, stake holders enlisted in
early program phases
Large target patient population
Staff and program coordinator fluent in
English and Creole
Preceptor fluent in English and Creole
Dedicated and experienced leadership
Culturally catered visual presentation and
pamphlets
Sufficient exam rooms for implementation
Program Coordinator Autonomy
Organized Workflow

•
•
•
•
•
•
•
•

Weaknesses
Quality improvement program to be
approved prior to implementation
Delayed IRB Approval
Inability to control vaccination acceptance
rates
COVID-19 Pandemic
Retention of office staff to promote
continuity of program
Participants need to have a basic reading
level
Shortened time frame
Novice Researcher

External Factors
•
•
•
•
•
•

Opportunities
Participants on site
Project Coordinator
Supportive management, staff, preceptor, and
graduate faculty
Benefit for providers to increase patient
healthcare knowledge, literacy, and
satisfaction
Increase office customer service ratings
Increase vaccine awareness to decrease
transmission of disease

•
•
•
•
•
•
•
•
•

Threats
Ensuring up to date COVID-19 vaccine
information is transmitted to patients
Managing time to avoid overlapping with
exam time
Availability of electronic devices
Ensuring patients are 55 years or older
MD coverage for medical questions
unknown to coordinator
Project Sustainability
Delayed IRB
Available personnel for effective
implementation
Electronic device malfunctioning
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5. Measurement Tools
Basic non-identifying demographic information were collected from participants, age,
and ethnicity. Participants were asked the following series of questions: 1) if they have
received the COVID-19 vaccine, 2) assess vaccination rates for participating subjects 3)
assess participant COVID-19 knowledge before and after quality improvement program,
4) assess participant satisfaction with the program. Next, the questionnaire will address 5)
participants willingness to be immunized with the COVID-19 vaccine, representing
participant vaccination acceptance. Lastly, questionnaire responses were used to calculate
risk of severe complications if a patient were to contract COVID-19 in relation to each
participant’s number of chronic illnesses.
As previously stated, participant’s individual questionnaire responses were to
assess the risk of a patient developing severe complications if they contracted the corona
virus and hospitalization. The risk calculator scale ranged from 2 to 15. The accumulated
points from five of the questionnaire questions (questions 1, 3, 7 and 9) were computed to
assess each individual participant’s risk of hospitalization or risk of symptom severity.
The higher the number on the scale the greater the risk of severe complications if
participant were to develop COVID-19. Majority of the questions were provided using a
5- point Likert scale ranging from strongly disagree to strongly agree answer format
(Malik et al. 2020). Survey responses allowed for the calculation of descriptive statistics
such as vaccine acceptance and willingness and patient program satisfaction.
Conclusively, using a confidence interval of 95% and a set p-value of 0.05, we were able
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to calculate a z-score to determine if the QI program implemented yielded statistically
significant results.
6. Protection of Human Subjects
An informational letter was provided prior to implementing the COVID-19
vaccination awareness program to each participant. Informational letters were provided in
English or Haitian Creole to cater to each participant’s primary language. Once
informational letters were provided and participants expressed interest, participants were
provided the voice-based PowerPoint presentation. At the end of the presentation all
participants had the option to click on the link provided or scan the QR code provided to
complete the 10-question questionnaire. Prior to check out participants were given an
educational pamphlet with COVID-19 vaccine information and locations in either
English or Haitian Creole.
Patients can benefit from increased health literacy, improved patient care satisfaction,
and from promotion of primary interventions such as vaccines. Implementation of the
COVID-19 vaccination awareness program does not pose any health risks to the
participants. The data collection process protects patient privacy by remaining in a
password protected electronic device and by omitting questions requiring primary patient
identifiers such as name and address. Once data entry is completed the data is secured in
a password protected computer, accessible by the DNP project leader. As previously
stated, no personal patient information will be disclosed, including participants refusing
to participant in the quality improvement program. The study was approved by the
Internal Review Board (IRB) at Florida International University prior to implementation.
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7. Data Collection
Data collection was implemented and obtained during the questionnaire portion of the
quality improvement program. The surveys were anonymous and did not require
participant identifying information such as name and address. Upon completion of the
COVID-19 vaccination awareness presentation via Ipad, participants were directed to a
Qualtrics link to be used either on the Ipad provided or on their personal device by
scanning a QR code provided. The educational intervention was administered prior to
health screening with physician to allow patients to discuss any COVID-19 related
questions with the primary care physician. In addition, patients were provided an
informative pamphlet catered to their primary language upon check out. Coordinator was
responsible for sorting and organizing the data collected, conduct data entry and analysis
from a remote location.
The survey, administered by Qualtrics, consisted of 10 questions formulated to assess
participant demographics, patient knowledge of the COVID-19 vaccine, patient
satisfaction with the COVID-19 Vaccination Awareness Program, vaccine confidence,
and vaccine acceptance (Table 2). Surveys and informational letters were provided in
English and Haitian Creole. Patient satisfaction was assessed using a rating scale from 1
to 5, with 1 being no benefit to the program and 5 signifying extreme benefit of
completing the program.
8. Data Analysis
Patient demographics were collected at the beginning of the questionnaire including
age and ethnicity. Analysis of the collected data was conducted by DNP project leader.
All survey results were stored securely in a password protected computer and a password
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protected Qualtrics account. All project members were trained prior to implementation of
the quality improvement program. All survey results were stored in a secured computer to
protect patient privacy. Data entry was stored and conducted on one computer and filed
daily during the 14-day implementation. The computer was password protected and
accessible only to DNP project coordinator. The anonymity of the surveys on Qualtrics
Table 2: COVID-19 vaccination awareness program questionnaire

protected patient information and did not include participant identifiers such as name and
address. No personnel information was collected from participants or shared during the
program, including participants refusing to participant in the quality improvement
program. Informational letter provided at the beginning of the presentation provided an
overview of data collection and distribution to offer patient assurance regarding patient
privacy. Ultimately, the survey was designed to assess and improve COVID-19
vaccination awareness, improve COVID-19 health literacy by providing culturally
sensitive and accurate health information to participants, identify vulnerable minority
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populations and assess benefits if implementing a quality improvement program in the
primary care setting.
VII.

Results

1. Findings
Combined the English and Creole speaking cohorts sample size produced: n=33.
Completion of the survey in its entirety could not be controlled and as a result three
questionnaires were excluded, reducing participation retention by 8%, participates recruited
(n=36), number of questionnaires retrieved (n=33). Majority of the participants were
primarily English speaking with about 21% of participants only Creole speaking. Using
excel to translate the data, approximately 58% (n= 19) of participants primary source of
knowledge was from television, increasing risk of misinformation and inaccurate statistics.
About 7% (n= 7) of participants were initially informed of the COVID-19 vaccine from a
health care provider.
Using the created COVID-19 severe complication risk calculator, 67% (n=22) of
participants were assigned a COVID-19 severity risk for strong, 30% (n=10) medium risk
and 3% (n=1). Approximately, 97% (n=32) of participants found the program to be
beneficial, while 3% (n=1) reported no benefit. Of the 33 participants included in the study
33% (n=11) of participants were unvaccinated and 67% (n= 22) reported being vaccinated.
Of the 11 participants that were unvaccinated, 91% (n=10) participants were willing to get
vaccinated post intervention and 7% (n=1) of participants reported no interest in
vaccination at all (Figure 1). Within the 33% of unvaccinated participants, 30% (n=3) of
the willing to be vaccinated group were primarily Creole speaking and 70% (n=7) primarily
English speaking.
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Figure 1: Vaccinated vs unvaccinated participants and willingness to get vaccinated
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Approximately 67% (n=22) of participants reported having little to no knowledge
regarding the COVID-19 vaccine pre intervention, this decreased to 6% (n=11) post
intervention. Findings suggest 33% (n=11) of participants reported having moderate to
extreme knowledge regarding the vaccine pre intervention this increased to 94% post
intervention, suggesting a 61% increase in patient awareness regarding COVID-19
vaccines (Figure 2).
Figure 2: Pre and post Quality improvement questionnaire assessment
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Conclusively, using a confidence interval of 95% and a set p-value of 0.05, we were able to
calculate a z-score to determine if the QI program implemented yielded statistically significant
results.
VIII. Discussion
1. Limitations
Implementation of the SWOT analysis prior to initiating the study allowed for identifying
potential future challenges. As a result, we were able to address challenges with
preconceived solutions. Initiation of the study was delayed by IRB approval and the
resubmission process. Initially the study was projected to last two months in Jan 2021 at
the peak of COVID-19 in South Florida. However, the study was delayed until October
2021 and shortened to two weeks. Consequently, projected sample size was shortened, still
within the approved sample size by the IRB.
The COVID-19 pandemic infection control guideline requirements significantly restricted
and limited patient interaction. Next, there was a delay in voice-based video production and
a delay in translation services. As a result, a voice-based PowerPoint presentation was
created to respect the approved IRB study deadline. Recruitment process could only be
implemented as time allowed without delaying the remaining practice workflow.
Limitation also included an inexperienced novice researcher; the navigation of the research
process may have been impacted.
In 2021, President Biden fortunately enforced vaccination mandates for private
businesses, social institutions, large employers, and healthcare workers which increased
vaccination rates. The two policies implemented by the Biden administration aimed to
increase vaccination, require employers with 100 or more employees to require staff to be
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fully vaccinated or tested weekly through the Occupational Safety and Health
Administration (OSHA). Furthermore, requiring health care workers employed by Center
for Medicare and Medicaid Services facilities to be vaccinated.
2. Implications for Advanced Practice Nursing
While there are many ways to disseminate the quality improvement program
results, the most successful dissemination strategy would be a poster presentation. DNP
project team hopes to submit the following QI program to be accepted by an accredited
academic nursing journal. The integration of the voice-based COVID-19 presentation in
patient waiting rooms to promote vaccination awareness may be implemented in the
future at the South Florida medical center. In the future, the COVID-19 vaccination
awareness program can be implemented with other languages. Furthermore, the
framework can be utilized for other patient wellness programs.
IX.

Conclusions
Despite limitations and challenges met during the study we were able to prepare
for alternative solutions for implementing the program. Lack of awareness and
vaccination will only contribute to the disproportionate rise that we continue to see in
African American older adults. Lack of addressing the issue while the virus continues to
spread can be very detrimental to minority races. Formulating an effective quality
improvement program targeted at increasing vaccination awareness and immunization
through influencing knowledge and building confidence. As vaccines and boosters
continue to be deployed it is the responsibility of healthcare providers to disseminate
culturally appropriate and accurate information to patients. Open communication,
willingness to prevent COVID-19, and a reliable support system can significantly impact
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the effectiveness of the program. Further, supporting the need for a multisectoral
approach. While the study did produce significant results, 61% increase in patient
awareness, there is still a lot to be done to achieve the recommended 70% herd immunity
for combating the COVID-19 pandemic.
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Appendix A.

COVID-19 Vaccination Awareness Program Timeline
Project Task

Time Frame

Develop framework for COVID 19
awareness program

January 20, 2021

Submission of goal statement and
action plan

January 24, 2021

Identification of clinical problem and
purpose, development of PICO question

February 1, 2021

Literature search, relevancy, and review

February 22,2021

Program planning, feasibility, and
SWOT analysis

March 15, 2021

Project proposal with educational
interventions, visual based presentation,
and questionnaires

July 10, 2021

DNP project approval

October 6, 2021

Implementation of COVID-19 Vaccination Awareness
Program, Data Collection

October 11, 2021

Data management, data analysis and finalization of
DNP project

November 29, 2021
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Appendix B.
INFORMATIONAL LETTER
Improving COVID-19 vaccination awareness and immunization in the African American
ages 55 and up at a South Florida Medical Center. A Quality Improvement Program
Hello, my name is Lissa Bazile APRN, MSN, DNP student. You have been chosen at random to
be in a research study about improving COVID-19 vaccine awareness in African American
patients ages 55 and older. The purpose of this study is to determine whether a COVID-19
vaccination awareness program can increase COVID-19 vaccination rates in African Americans
ages 55 and older. If you decide to be in this study, you will be one of 60 – 100 people in this
research study. Participation in this study will take 20 minutes of your time. If you agree to be
in the study, I will ask you to do the following things:
1. Patients will watch a voice-recorded presentation in English or Creole using an Ipad provided
regarding the COVID-19 virus, benefits of COVID-19 vaccine and positives behaviors for
preventing COVID-19. At the end of the presentation, patients will complete a 10-question
survey to evaluate effectiveness of COVID-19 awareness program.
2. The survey questions will be administered via Qualtrics in English or Creole, patient choice.
It is a survey software used to create, gather, and assess survey data. At the end of
presentation patients will be directed to survey questions on the Ipad. Participants will be
instructed to complete the survey and submit questions to researcher.
3. Upon discharge, participants will be provided a pamphlet including important information
from the COVID-19 presentation and a list of local vaccination sites.
There are no foreseeable risks or benefits to you for participating in this study. It is expected that
this study will benefit society by increasing COVID-19 vaccine knowledge and health selfsufficiency in African American patients ages 55 and up. It is also expected to increase
vaccination rates in African American patients 55 years of age or older.
There is no cost or payment to you. If you have questions while taking part, please stop me and
ask. Your answers will remain confidential and anonymous.
If you have questions for one of the researchers conducting this study, you may contact my
graduate instructor Dr. Dana Sherman DNP, APRN, ANP-BC, FNP-BC at (305) 348- 2247 or
Lissa Bazile APRN, MSN, DNP student as (954) 512-4679.
If you would like to talk with someone about your rights of being a subject in this research study
or about ethical issues with this research study, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu.
Your participation in this research is voluntary, and you will not be penalized or lose benefits if
you refuse to participate or decide to stop. You may keep a copy of this form for your records.
All clinical questions and issues should be directed to your treating physician.
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Appendix C.
LÈT ENFATIONALMASYONAL
Amelyore konsyantizasyon vaksinasyon COVID-19 ak vaksinasyon nan Afriken Ameriken
ki gen laj 55 ak plis nan yon Sid Florid Medical Center. Yon Pwogram Amelyorasyon
Kalite
Bonjou, non mwen se Lissa Bazile APRN, MSN, DNP elèv. Ou te chwazi o aza yo dwe nan yon
etid rechèch sou amelyore konsyans vaksen COVID-19 nan pasyan Afriken Ameriken ki gen laj
55 ak pi gran. Rezon ki fè etid sa a se detèmine si yon pwogram konsyantizasyon vaksen
COVID-19 ka ogmante pousantaj vaksinasyon COVID-19 nan Afriken Ameriken ki gen laj 55
ak pi gran. Si ou deside yo dwe nan etid sa a, ou pral youn nan 60 - 100 moun ki nan etid rechèch
sa a. Patisipasyon nan etid sa a pral pran 20 minit nan tan ou. Si ou dakò yo dwe nan etid la,
mwen pral mande w fè bagay sa yo:
1. Pasyan yo ap gade yon prezantasyon anrejistre vwa nan lang angle oswa kreyòl lè l sèvi avèk
yon Ipad bay konsènan viris la COVID-19, benefis nan vaksen COVID-19 ak konpòtman
pozitif pou anpeche COVID-19. Nan fen prezantasyon an, pasyan yo pral ranpli yon sondaj
10-kesyon yo evalye efikasite nan pwogram konsyantizasyon COVID-19.
2. Kesyon yo sondaj yo pral administre atravè Sondaj makak nan lang angle oswa kreyòl, pasyan
chwa. Li se yon lojisyèl sondaj itilize yo kreye, ranmase ak bourik done sondaj. Nan fen
prezantasyon pasyan yo pral dirije yo sou kesyon sondaj sou Ipad la. Patisipan yo pral enstwi
ranpli sondaj la epi soumèt kesyon bay chèchè.
3. Lè yo egzeyate, patisipan yo pral bay yon ti liv ki gen ladan enfòmasyon enpòtan nan
prezantasyon COVID-19 la ak yon lis sit vaksinasyon lokal yo.
Pa gen okenn risk previzib oswa benefis pou ou pou patisipe nan etid sa a. Li espere ke etid sa a
pral benefisye sosyete a lè yo ogmante konesans vaksen COVID-19 ak sante endepandan sante
nan pasyan Afriken Ameriken ki gen laj 55 ak yo. Li espere tou ogmante pousantaj vaksinasyon
nan pasyan Afriken Ameriken ki gen 55 an oswa plis.
Pa gen okenn pri oswa peman pou ou. Si ou gen kesyon pandan w ap pran pati, tanpri sispann m
'epi mande. Repons ou yo ap rete konfidansyèl e anonim.
Si ou gen kesyon pou youn nan chèchè yo ki fè etid sa a, ou ka kontakte enstriktè gradye mwen
an Dana Sherman DNP, APRN, ANP-BC, FNP-BC nan (305) 348- 2247 oswa Lissa Bazile
APRN, MSN, DNP elèv kòm (954) 512-4679.
Si ou ta renmen pale ak yon moun sou dwa ou pou yo te yon sijè nan etid rechèch sa a oswa sou
pwoblèm etik ak etid rechèch sa a, ou ka kontakte Biwo FIU nan Entegrite Rechèch pa telefòn
nan 305-348-2494 oswa pa imèl nan ori@fiu.edu.
Patisipasyon ou nan rechèch sa a se volontè, epi ou pa pral penalize oswa pèdi benefis si ou
refize patisipe oswa deside sispann. Ou ka kenbe yon kopi fòm sa a pou dosye ou. Tout kesyon
klinik ak pwoblèm yo ta dwe dirije yo sou doktè trete ou.

Paj 41 nan 54
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Appendix D

COVID-19 Vaccination Awareness Program Questionnaire
1)

Age: __________________________

2)

Ethnicity: ______________________

3) Have you received any of the approved COVID-19 vaccines? (Circle One) Yes or No
If NO, why not? _______________________________________________________________
4) How would you rate your knowledge of the COVID-19 vaccine PRIOR to the
presentation? (Circle One)
1- No Knowledge

4- Moderate Knowledge

2- Little Knowledge

5- Extreme Knowledge

3- Some Knowledge
5)

How did you learn about the COVID-19 vaccines? (Circle One)
1234-

Television
Newspaper/ Magazine
Websites
Family and Friends

5- Healthcare Provider (ex: doctor,
nurse, nurse practitioner, physician
assistant)
6- Health Officials (Center for Disease
Control, World Health Organization)
7- Social Media (ex: Facebook)

6) How confident were you in the COVID-19 vaccine PRIOR to the presentation? (Circle
One)
1- No confidence

4- Moderately confident

2- Barely confident

5- Extremely Confident

3- Neutral
7) With the information provided to you today, if made available and recommended for
you, how likely are you willing to take the COVID-19 vaccine? (Circle One)
1-

Not Likely

4-

Moderate likely

2-

Somewhat not likely

5-

Extremely likely

3-

Neutral

COVID-19 VACCINE AWARENESS IN BLACKS AGES 55 AND UP
8)

How would you rate the COVID-19 Vaccination Awareness Program?

1-

No Benefit

4-

Moderate Benefit

2-

Little Benefit

5-

Extreme Benefit

3-

Neutral
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9) How many chronic illnesses have you been diagnosed with? (Circle One)
1- (0- 3 medical conditions)
2- (4- 7 medical conditions)
3- (8 or greater medical conditions)
10) How would you rate your knowledge of the COVID-19 vaccine AFTER the
presentation? (Circle One)
1- No Knowledge

4- Moderate Knowledge

2- Little Knowledge

5- Extreme Knowledge

3- Some Knowledge
Thank you for participating in the COVID-19 vaccine awareness quality improvement project. ☺

Survey Citation: Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020).
Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine, 26, 100495.

Appendix E

COVID-19 Pwogram Konsyantizasyon Vaksinasyon Kesyonè
1) Laj: __________________________
2) Etnisite: ______________________
3) Eske ou te resevwa nenpòt nan vaksen COVID-19 apwouve yo?(Sèk Youn) Wi oswa Non
Si non, poukisa? _______________________________________________________________
4) Ki jan ou ta evalye konesans ou sou vaksen COVID-19 la? (Sèk Youn)
1- Pa gen konesans

4- Konesans modere

2- Ti Konesans

5- Konesans ekstrèm

3- Kèk Konesans
5)

Ki jan ou te aprann sou vaksen COVID-19 yo? (Sèk Youn)
1- Televizyon

6- Ofisyèl Sante (Sant pou Kontwòl

2- Jounal / Magazin

Maladi, Organizationganizasyon

3- Sit wèb

Mondyal Lasante)

4- Fanmi ak Zanmi

7- Medya sosyal (ansyen: Facebook)

5- Founisè Swen Sante (ansyen: doktè,
enfimyè, enfimyè pratikan, asistan
doktè)
6) Ki jan ou gen konfyans nan vaksen COVID-19 la ANVAN prezantasyon an? (Sèk Youn)
1- Pa gen konfyans

4- Modere konfyans

2- Apèn konfyans

5- Trè konfyans

3- Net
7) Avèk enfòmasyon yo ba ou jodi a, si disponib epi rekòmande pou ou, ki jan ou vle pran
vaksen COVID-19 la? (Sèk Youn)
1- 1-Pa gen chans

4- Modere gen anpil chans

2- Yon ti jan pa gen anpil chans

5- Gen anpil chans

3- Net

8) Ki jan ou ta evalye Pwogram Konsyantizasyon Vaksinasyon COVID-19 la?
1- Pa gen Benefis

4- Benefis modere

2- Ti Benefis

5- Benefis ekstrèm

3- Net

9) Konbyen maladi kwonik ou te dyagnostike ak? (Sèk Youn)
1- (0-3 kondisyon medikal)
2- (4-7 kondisyon medikal)
3- (8 oswa plis kondisyon medikal)
10) Ki jan ou gen konfyans nan vaksen COVID-19 la APRE prezantasyon an? (Sèk Youn)
1- Pa gen konfyans

4- Modere konfyans

2- Apèn konfyans

5- Trè konfyans

3- Net
Mèsi pou patisipe nan pwojè amelyorasyon kalite vaksen COVID-19 la. ☺

Sitasyon Sondaj: Malik, AA, McFadden, SM, Elharake, J., & Omer, SB (2020). Detèminan nan
akseptasyon vaksen COVID-19 nan peyi Etazini an. Medikal klinik,26, 100495.

Appendix F

COIVD-19 Vaccination Awareness Program Questionnaire Scoring
1)

Age: __________________________ (+1 point)

2)

Ethnicity: ______________________ (+1 point)

3) Have you received any of the approved COVID-19 vaccines? (Circle One) Yes or
No (Yes= 0 points, No = +1 point)
If NO, why not? _______________________________________________________________
4) How would you rate your knowledge of the COVID-19 vaccine PRIOR to the
presentation? (Circle One) (Little to No knowledge = 2 points, Some Knowledge= 1 point,
Moderate to Extreme Knowledge = 0 points)
1- No Knowledge

4- Moderate Knowledge

2- Little Knowledge

5- Extreme Knowledge

3- Some Knowledge
5)

How did you learn about the COVID-19 vaccines? (Circle One)
12345-

Television (+1 point)
Newspaper/ Magazine (+1 point)
Websites (+1 point)
Family and Friends (+1 point)
Healthcare Provider (ex: doctor,
nurse, nurse practitioner, physician
assistant) (+0 points)

6- Health Officials (Center for Disease
Control, World Health Organization)
(+0 points)
7- Social Media (ex: Facebook) (+1
point)

6) How confident were you in the COVID-19 vaccine PRIOR to the presentation? (Circle
One) (Barely to No confidence = 2 points, Neutral= 1 point, Moderate to Extreme
Confidence = 0 points)
1- No confidence

4- Moderately confident

2- Barely confident

5- Extremely Confident

3- Neutral
7) With the information provided to you today, if made available and recommended for
you, how likely are you willing to take the COVID-19 vaccine? (Circle One) (Not to
Somewhat Likely = 2 points, Neutral = 1 point, Moderate to Extreme Likely = 0 points)
1-

Not Likely

3-

Neutral

2-

Somewhat not likely

4-

Moderate likely

5-

Extremely likely

8) How would you rate the COVID-19 Vaccination Awareness Program? (+0 points)
1- No Benefit

4-

Moderate Benefit

2- Little Benefit

5-

Extreme Benefit

3-

Neutral

9) How many chronic illnesses have you been diagnosed with? (Circle One)
1- (0- 3 medical conditions) (+ 1 points)
2- (4- 7 medical conditions) (+ 2 points)
3- (8 or greater medical conditions) (+3 points)
10) How would you rate your knowledge of the COVID-19 vaccine AFTER the
presentation? (Circle One) (Little to No knowledge = 2 points, Some Knowledge= 1 point,
Moderate to Extreme Knowledge = 0 points)
1- No Knowledge

4- Moderate Knowledge

2- Little Knowledge

5- Extreme Knowledge

3- Some Knowledge

Thank you for participating in the COVID-19 vaccine awareness quality improvement project. ☺
Score Range: 2-15 points
Risk Calculator: 2 – 5: Medium Risk

6-10: Strong Risk

11-15: Extreme Risk

Collectively all questions will be to assess COVID-19 Risk and willingness to get vaccinated and
vaccination rates among African Americans ages 55 and up.

Survey Citation: Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020).
Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine, 26, 100495.
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Appendix K
Office of Research Integrity
Research Compliance, MARC 414

MEMORANDUM
To:
CC:

Dr. Dana Sherman
Lissa Bazile

From:

Maria Melendez-Vargas, MIBA, IRB Coordinator

Date:

September 29, 2021

Protocol Title:

“Increasing COVID-19 vaccination awareness and immunization in the
African American ages 55 and up- A Quality Improvement Program”

The Florida International University Office of Research Integrity has reviewed your research
study for the use of human subjects and deemed it Exempt via the Exempt Review process.
IRB Protocol Exemption #: IRB-21-0421 IRB Exemption Date:
Reference #: 110757

09/29/21 TOPAZ

As a requirement of IRB Exemption you are required to:
1) Submit an IRB Exempt Amendment Form for all proposed additions or changes in the
procedures involving human subjects. All additions and changes must be reviewed and
approved prior to implementation.
2) Promptly submit an IRB Exempt Event Report Form for every serious or unusual or
unanticipated adverse event, problems with the rights or welfare of the human subjects, and/or
deviations from the approved protocol.
3) Submit an IRB Exempt Project Completion Report Form when the study is finished or
discontinued.
Special Conditions: N/A

For further information, you may visit the IRB website at http://research.fiu.edu/irb.
MMV/em

